Litcius/Paper detail

The rise of mucormycosis in Covid-19 patients in India

Mrigesh Bhatia

2021Expert Review of Anti-infective Therapy32 citationsDOI

Abstract

The health-care system in India has been unable to cope with the onslaught of wave 2 Covid-19 pandemic. At its peak in early May 2021, over 400,000 cases of Covid-19 were being reported on a daily ...

Topics & Concepts

Coronavirus disease 2019 (COVID-19)PandemicMucormycosis2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyInternal medicinePathologyOutbreakDiseaseInfectious disease (medical specialty)Antifungal resistance and susceptibility
The rise of mucormycosis in Covid-19 patients in India | Litcius